Myositis International Health & Research Collaborative Alliance

Creating a world where we can cure myositis together✨.

Well-being warning🌻: this site may feature images of nature to create a peaceful🌿experience for our visitors🌿

Welcome to MIHRA’s Single-Page Seedling 🌱 Web-site!

Functional for Now with a ✨ Wildly Web Bright Future ✨to Come in a Few Weeks!

Myositis-Related Conditions are:

Rare Diseases

Challenging for Living

Challenging For Research

MIHRA is a non-profit science, education & advocacy organization of international multi-disciplinary, multi-specialty experts (including patients) focused on better living & research across myositis-related disorders.

MIHRA recognizes myositis takes on many forms beyond muscle.

The MIHRA research community is working to represent the wide spectrum of the myositis disease experience within research and in care.

MIHRA VISION

To Create a World Where We Can Cure Myositis Together

MIHRA MISSION
  • To optimize the health & well-being of people living with myositis worldwide.
  • To cultivate global expertise and promote synergy across myositis endeavors.
  • To secure future research and clinical care through mentorship programs and education.
  • To drive international collaborative research and clinical trial readiness in myositis.

FIVE MIHRA CORES

  • Clinical Trial Readiness
  • Database Harmonization
  • Education, Mentorship & Career Advancement
  • Excellence in Clinical Care
  • Global Engagement & Equity

Making clinical trial more accurate and available to patients.

Learning about myositis from sharing worldwide anonymous disease information.

Ensuring the future of myositis research through proactive mentorship of careers in myositis.

Expanding and fortifying worldwide clinical confidence in diagnosing and caring for people living with myositis.

Inclusion of myositis expertise and care across disciplines, specialties, geography and socioeconomic strata.

MIHRA Myositis University

In collaboration with our partners at The Myositis Association (TMA) and Post-Graduate Institute of Medicine (PIM). Cost-free professional accredited education to enhance worldwide knowledge in diagnosis and care of people living with myositis. Up to 30 CME/MOC/CE/CEUs to be launched April 2024 – to include accreditation for all specialties and disciplines. This is also a learning and advocacy resource for people living with myositis related conditions.

Many thanks to Ms. Ingrid deGroot, Drs, Floranne Ernste, Helene Alexanderson, Julie Paik, Lesley Ann Saketkoo, Lisa Christopher-Stine, and Malin Regardt for coordinating this effort.

MIHRA Myositis Specialty Clinics

Coming soon to this web-site! A worldwide listing of clinics specializing in adult and pediatric myositis related disorders.

People living with myositis-related disorders and their loved ones will be able to locate myositis specialty clinics and centers that is convenient for them or in a city they can easily get to. Myositis Specialty Centers commonly share care with local clinicians (general dermatologists, rheumatologists, neurologists, pulmonologists, etc.) – and together work as a team to provide clinical excellence.

Please contact a MIHRA representative to request Specialty Center applications for your clinic

Many thanks to Drs. Jessica Day, Myma Albayda and Pari Basharat for coordinating this effort.

MIHRA Current Clinical Studies Listings

Coming soon to this web-site! Worldwide listing of ongoing clinical trials and studies in pediatric and adult myositis-related disorders.

Visitors (clinicians and patients) will be able to peruse the listings according to disease sub-type. The listing provides easy to find information about existing studies in Myositis disorders and how to contact study investigators.

The listing also serves as a snapshot of the current clinical research landscape for myositis researchers. We hope this effort leads to strong multi-center collaborations.

Many thanks to Drs. Jessica Day, Myma Albayda and Pari Basharat for coordinating this effort. Special thanks to Dr. Karen Cheng and iMyoS.

MIHRA Clinical Trials Site Network

The MIHRA CTSN is a community of newly emerging and long-established research sites in Myositis-related disorders.

The MIHRA CTSN enables mapping of global site resources to inform feasible and efficient clinical trials design and development.

The MIHRA CTSN serves as a community-based platform for trial sites to learn from each other and to support global growth of resources for optimal clinical trial implementation.

Please contact a MIHRA representative to register your research site.

Many thanks to Drs. Antonia Valenzuela and Lesley Ann Saketkoo for coordinating this effort.

Join Us at GCOM 2024!!

Friday Evening 15 March 2024 – doors open at 6pm .. come say hello to the residents at Pittsburgh’s National Aviary!

MIHRA and iMyoS: Celebrating 25 Years of International Collaborative Research in Myositis!

  • 6pm Doors Open at the Garden House – Be Prepared for Laughter, Fellowship, Fun and Dancing
  • 6 to 7:30 pm Event Registrants will have access to the National Aviary’s Free-Habitat Exhibits and Supervised Animal Encounters with National Aviary Residents – maybe a sweet sloth, penguin, owl, toucan, eagle …
  • At 7:30pm 25 Years History and Remembrance of Dr. Paul H. Plotz led by Drs. Lisa Rider, Fred Miller, Lisa Christopher-Stine, Ingrid Lundberg, Jiri Vencovsky, Chet Oddis – and stories from the crowd!
  • Simple but Ample Artisan Fare, Extremely reasonable cash bar
  • Dancing until 11pm – ❤️ Celebrating ALL Mobility Stylings on the Dance Floor❤️
Photos of the National Aviary Animals in Pittsburgh: Penguins, Flamingo, Tucan, Owl, Eagle and a Sloth upside down

Join Us at GCOM 2024 at the National Aviary!

Doors Open at 6pm * Animal Encounters until 7:30pm Memory Lane starts at 7:30pm * Dancing until 11pm Fully Accessible Event for all Mobility Stylings!!!

Are You With Industry at GCOM 2024?

Come Meet MIHRA Leadership and Learn About MIHRA Programming with Industry Partners Friday Morning 🐣

MIHRA is humbled to announce the Dr. Paul H. Plotz Endowment for Global Education, Research Acceleration & Career Enhancement in Myositis

  • This year 9 Researchers from 7 Countries and Across Multiple Disciplines (Nursing, Occupational Therapy, Physical Therapy, Medical Students and Physicians) received awards to attend the GCOM 2024 Conference in Pittsburgh this year!
  • Special thank you to the GCOM, iMyos and MIHRA award review committee. Especially to Ms. Barbara Shafranski and Drs. Latika Gupta and Lisa Christopher-Stine
  • MIHRA Financial Committee is comprised of Ms. Barbara Shafranski (treasurer), Dr. Lisa Christopher-Stine, Dr. Mazen Dimachkie (vice-treasurer)

Meet the

✨Leadership Team✨

The founding team of dedicated experts🌿 in myositis-related conditions working hard for worldwide collaboration to cure myositis together✨

Barbara Shafranski

Patient Research Partner

Legal & Organizational Advisor

New Jersey, USA

Elie Naddaf

Neurology

Mayo Clinic

Rochester, MN, USA

Floranne Ernste

Rheumatology

Mayo Clinic

Rochester, MN, USA

Helene Alexanderson

Physical Therapy

Karolinksa Institutet,

Stockholm, Sweden

Julie Paik

Rheumatology

Johns Hopkins University

Baltimore, MD, USA

Mazen Dimachkie

Neurology

University of Kansas

Kansas City, KS, USA

Lesley Ann Saketkoo

Adult & Pediatric Rheumatology/ Pulmonary Focus

LSU & Tulane University

New Orleans, Louisiana, USA

Pedro Machado

Rheumatology/

Neurology Focus

University College London

London, United Kingdom

Alejandro Benitez

Rheumatology

Universidad de Buenos Aires

Buenos Aires, Argentina

Antonia Valenzuela

Rheumatology

Pontificia Universidad Católica de Chile

Santiago, Chile

Christian Lood

Translational Science

University of Washington

Seattle, Washington, USA

Christopher Mecoli

Rheumatology

Johns Hopkins University

Baltimore, Maryland, USA

Didem Saygin

Rheumatology

University of Pittsburgh

Pittsburgh, Pennsylvania, USA

Jemima Albayda

Rheumatology

Johns Hopkins University

Baltimore, Maryland, USA

Jessica Day

Rheumatology

Walter & Eliza Hall Institute for Medical Research

Melbourne, Australia

Latika Gupta

Rheumatology

Royal Wolverhampton Hospitals NHS

University of Manchester

Manchester, England, UK

Malin Regardt

Occupational Therapy

Karolinska Institutet

Stockholm, Sweden

Pari Basharat

Rheumatology

Western University

London, Ontario, Canada

Anneli Dihkan

Swedish Working Group for Myositis, Swedish Rheumatism Association

Barbara Shafranski

Treasurer, MIHRA Foundation

Christine Lowe

Myositis Association Australia

Ingrid de Groot

Dutch Myositis Working Group

European Myositis Network

Irene Oakley

Myositis UK

Joe Sanchez

US Myositis and IBM Social Media Influencer

Karen Cheng

iMyos, Associate Board Member

Rachel Bromley

Patient Education, Support & Advocacy

The Myositis Association (TMA)

Roland Mischke

ENMC

German Myositis Group

Silke Schlüter

German Myositis Group

iMyoS, Board of Directors

Suzanne Edison

Cure JM

Mental Health Coordinator

Annet Van Royen

Pediatric Rheumatology

University of Utrecht

Netherlands

Bianca Lang

Pediatric Rheumatology

Dalhousie University

Nova Scotia, Canada

Chester Oddis

Rheumatology

University of Pittsburgh

USA

Fredrick W. Miller

Rheumatology / Immunology

NIH NIEHS, USA

Ingrid Lundberg

Rheumatology

Karolinska Institutet

Stockholm, Sweden

Jiri Vencovsky

Institute of Rheumatology

Prague, Czech Republic

Lisa Christopher-Stine

Rheumatology

Johns Hopkins University

Baltimore, USA

Masataka Kuwana

Rheumatology /Immunology

Nippon Medical School

Tokyo, Japan

Victoria Werth

Dermatology

University of Pennsylvania

USA

Skin

Skin is commonly involved in Juvenile Myositis, Dermatomyositis and Anti-Synthetase syndrome. Skin involvement can be the most concerning experience for people living with myositis. MIHRA recognizes this and is working to make sure people with skin-predominant myositis are strongly represented in research.

Juvenile Myositis

This is just a placeholder to help you visualize how the content is displayed in the tabs. Feel free to edit this with your actual content.

Dermatomyositis

This is just a placeholder to help you visualize how the content is displayed in the tabs. Feel free to edit this with your actual content.

Polymyositis

This is just a placeholder to help you visualize how the content is displayed in the tabs. Feel free to edit this with your actual content.

Anti-synthetase Syndrome

Immune-Mediated Necrotizing Myopathy

Inclusion Body Myositis

MIHRA recognizes myositis takes on many forms that often goes beyond muscle. The MIHRA research community is working to represent the very wide spectrum of disease experience within research and in care.

MIHRA Friendships, Collaborations & Network Members … coming here soon✨

Watch, Read, Listen – Community News with Stories of Peer Leaders, Patient Insights, and Established and Emerging Specialty Center Journeys – and Upcoming Events COMING SOON!!!

Muscle

This is just a placeholder to help you visualize how the content is displayed in the tabs. Feel free to edit this with your actual content.

Lungs

This is just a placeholder to help you visualize how the content is displayed in the tabs. Feel free to edit this with your actual content.

Diaphragm

The diaphragm is the large muscle that lies between the chest and the abdomen that is essential for inhalation and expiration of breath. The diaphragm is also a core muscle that impacts balance and spinal alignment. Involvement of the diaphragm in myositis is often an under-recognized concern which is important to the MIHRA research community.

Gastrointestinal

Joints

MIHRA COMING SOON

Stay in the loop with everything you need to know.